Chimeric antigen receptors (CARs) and their use in novel cancer therapies

In this article, Sino Biological demonstrates how Chimeric Antigen Receptors (CARs) can be utilized in novel cancer therapies, a change from the usual application of CARs, which heavily feature T-cells.

Related Keywords

South Korea ,Han ,Alex Smith ,Silva Santurio ,Sino Biological Inc ,Biomarker Research ,Sino Biological Inc Apr ,Drug Administration ,Sponsored Content ,Natural Killer ,Chimeric Antigen Receptor ,Novel Therapeutic Cell Type ,Cancer Immune Cell ,Out Like ,Cells Toward Enhanced Efficacy ,Systematic Review ,Reviews Cancer ,Sino Biological ,Content Policy ,News Medical Net ,Cancer Therapies ,